Rodin Therapeutics is leveraging groundbreaking biology and a quantum-mechanics inspired chemistry approach to develop new drugs for Alzheimer's disease.
Patients with Alzheimer's Disease and other causes of cognitive decline lack effective therapies to reverse or slow the progression of the disease and loss of quality of life.
Rodin's novel drug target, when inhibited, can enhance the expression of genes critical for the formation of new memories. Animal models of Alzheimer's treated in this way show a profound improvement in learning. The Rodin compound, when approved, could help slow cognitive decline and improve quality of life for patients throughout the course of their disease.